Animal Models and Experimental Medicine is a prestigious open-access journal published by WILEY that has been a significant contribution to the field of biomedical research since its inception in 2018. Focusing on the role of animal models in the exploration of experimental medicine, the journal has garnered attention for its rigorous peer-reviewed articles that bridge laboratory research with clinical applications. The journal currently holds impressive quartile rankings, including Q1 in Medical Laboratory Technology, Veterinary (miscellaneous), and strong standings across various other categories, reflecting its reputable position within the Scopus rankings. With a commitment to disseminating high-quality research that advances knowledge and practice in veterinary and medical sciences, Animal Models and Experimental Medicine offers a platform for researchers, professionals, and students to contribute to and stay informed about pivotal developments in the field. As an open-access journal, it ensures accessibility, encouraging a wider readership and fostering collaboration among the scientific community.

Biomed Research International is a prominent open access journal published by HINDAWI LTD, dedicated to advancing the field of biomedical research. With its ISSN 2314-6133 and E-ISSN 2314-6141, this journal has been a significant contributor to the scientific community since its inception in 2013, making scholarly work accessible to a global audience. The journal's scope encompasses a range of disciplines, including biochemistry, genetics, molecular biology, immunology, microbiology, and medicine, reflecting its commitment to interdisciplinary research. Ranked in the Q2 quartile as of 2023 across several relevant categories, Biomed Research International is recognized for its high-quality publications that foster innovation and collaboration in biomedical studies. Researchers, professionals, and students looking to share and gain insights into cutting-edge biomedical discoveries will find this journal an essential resource. With a focus on rapid dissemination of research findings, the journal serves as a vital platform for academics to engage with contemporary issues in health and disease, ultimately contributing to the advancement of medical science.

Biology Direct is a leading open-access journal published by BMC, dedicated to disseminating groundbreaking research in the fields of biological sciences. Since its inception in 2006, the journal has emerged as a pivotal platform for scholars, researchers, and practitioners, providing unrestricted access to high-quality, peer-reviewed articles that cover a wide spectrum of topics, including biochemistry, ecology, and applied mathematics. With an impressive ranking in the first quartile across multiple scientific categories, including Agricultural and Biological Sciences and Biochemistry, Genetics, and Molecular Biology, Biology Direct is recognized for its rigorous standards and impactful contributions within the academic community. The journal's open-access model ensures that research findings reach a global audience, fostering collaboration and innovation. Researchers and students looking to stay ahead in the rapidly evolving biological sciences will find Biology Direct an invaluable resource for knowledge and insight.

FASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE is a prestigious journal published by SPRINGER, dedicated to advancing knowledge in the fields of biochemistry, genetics, molecular biology, and medicine. Established in 1956 and continuing to be relevant through to 2024, this journal provides a vital platform for researchers to publish original findings and significant reviews that contribute to these essential disciplines. With an ISSN of 0007-4888 and an E-ISSN of 1573-8221, it enjoys a respectable standing in the academic community, currently positioned in the Q3 quartile of both Biochemistry, Genetics and Molecular Biology, and Medicine categories for 2023. Despite its traditional subscription model, the journal reaches a wide audience of professionals, students, and researchers, who benefit from timely access to impactful research and experimental studies. By fostering a rich dialogue in experimental biology and medicine, this journal plays an important role in shaping ongoing research and understanding of complex biological systems.

Open Life Sciences is a distinguished open-access journal published by DE GRUYTER POLAND SP Z O O, dedicated to advancing research across diverse disciplines in the life sciences. Since its inception in 2014 and transitioning to open access in 2015, the journal has become a pivotal platform for researchers, fostering the dissemination of high-quality scientific work while ensuring that valuable findings are freely accessible to the global community. With an impressive categorization into Q2 in Agricultural and Biological Sciences and Q3 in several other fields including Biochemistry and Immunology as of 2023, Open Life Sciences promotes innovation and knowledge sharing across its broad spectrum of topics. The journal's commitment to excellence is reflected in its competitive Scopus rankings, making it an essential resource for professionals and students alike who are keen to stay at the forefront of life sciences research.

Quantitative Biology is a prestigious journal published by WILEY, focusing on the interdisciplinary study of quantitative approaches in the biological sciences. With an ISSN of 2095-4689 and an E-ISSN of 2095-4697, this journal has established itself as a critical platform for researchers exploring complex biological systems through mathematical and computational methodologies. Operating out of China, Quantitative Biology significantly contributes to its field, holding a Q2 ranking in various categories, including Applied Mathematics and Biochemistry, Genetics and Molecular Biology, according to the latest Scopus rankings. These rankings reflect the journal's commitment to publishing high-quality research that employs advanced modeling and simulation techniques. The journal's impact is evident with its position in the 84th percentile for Applied Mathematics, indicating its relevance and growth in a competitive academic landscape. Although it does not currently operate under an Open Access model, the journal is pivotal for professionals and students alike, aiming to bridge the gap between mathematical theories and biological applications. Researchers are encouraged to submit their innovative findings and engage with the vibrant community dedicated to advancing the quantitative understanding of biological phenomena.

Welcome to Advances in Clinical and Experimental Medicine, an esteemed publication by WROCLAW MEDICAL UNIVERSITY, dedicated to advancing the essential fields of clinical and experimental medicine. With an open access model since 2017, this journal ensures that researchers, healthcare professionals, and students worldwide can freely access high-quality scientific content. Covering a broad spectrum of topics including biochemistry, genetics, internal medicine, and pharmacology, Advances in Clinical and Experimental Medicine has established itself as a pivotal resource in the scientific community, currently holding prestigious rankings such as Q2 in Biochemistry, Genetics, and Molecular Biology (miscellaneous) and Q1 in Reviews and References (medical) for 2023. Spanning over two decades of rigorous research publication, the journal is a critical platform for sharing innovative findings and fostering collaboration among scholars, making it an invaluable asset for those at the forefront of medical science.

Biomedical Research and Therapy is a pioneering journal published by BIOMEDPRESS, dedicated to the field of biomedical sciences. With its ISSN 2198-4093, this journal aims to disseminate high-quality research and innovative therapies that advance knowledge in biomedical research. Although it operates on a non-open access model, it provides crucial insights into various topics such as drug discovery, disease mechanisms, regenerative medicine, and clinical applications. The journal's rigorous peer-review process ensures the publication of critical findings and methodologies, making it a vital resource for researchers, practitioners, and students interested in the constantly evolving landscape of biomedical research. With converged years from 2020 to 2024 and an emerging reputation in its field, Biomedical Research and Therapy is positioned to contribute significantly to the global scientific community, enriching the discourse around therapeutic advancements and biomedical innovations.

Cell Reports Medicine, published by Cell Press, represents a pivotal advancement in the open access landscape of biomedical research since its inception in 2020. With a dedicated focus on the intersection of medicine, biochemistry, genetics, and molecular biology, this journal has quickly established itself as a key resource, earning a remarkable Q1 ranking in these fields. Based in the United States, Cell Reports Medicine boasts impressive metrics, ranking #25 out of 636 in General Medicine and #18 out of 221 in Biochemistry, underscoring its influence and reach within the scientific community, with a notable 96th and 92nd percentile respectively. As a fully open access journal, it fosters global dissemination of knowledge, ensuring that groundbreaking research is readily available to researchers, professionals, and students alike. The journal not only promotes high-quality research but also aims to bridge the gap between molecular discoveries and clinical applications, making it an essential addition to any academic library or researcher's toolkit.